Finance

Cytek BioSciences could be valued at more than $2.3 billion as IPO terms have been set

The company expects there to be 130.81 million shares outstanding after the IPO. The stock is expected to list on the Nasdaq under the ticker symbol " …

Read more @ www.marketwatch.com

Back to top button